The Acute and Chronic Effects of Fruit Polyphenols on Chronic Disease (PPF)
A Randomized Placebo Controlled Trial to Test the Acute and Chronic Effects of Fruit Polyphenols on Postprandial Indices of Chronic Disease (PPF)
1 other identifier
interventional
34
1 country
1
Brief Summary
- 1.The primary objective is to determine the effect of fruit polyphenols on postprandial lipoprotein triglyceride metabolism after consumption a standard high carbohydrate/fat breakfast meal with a beverage rich in fruit-derived polyphenols compared to energy and macro-/micro-nutrient matched control beverage (acute, Part 1).
- 2.Secondary objectives are: 1)to assess the effects of consuming daily for 8 weeks (chronic, Part 2) a beverage rich in fruit polyphenols compared to an energy and macro-/micro- nutrient matched control beverage on fasting glucose, insulin, lipids and markers of oxidative stress; and 2) to assess the effects of these beverages on meal-related changes in metabolic and oxidative stress measures after 8 weeks daily consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2012
CompletedFirst Posted
Study publicly available on registry
November 21, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2018
CompletedJuly 27, 2021
July 1, 2021
1.3 years
November 8, 2012
July 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Plasma Triglycerides Concentrations
Changes in Plasma Triglyceride concentrations during the acute phases (from 0 to 6 hrs) and over the chronic phase, assessed by iAUC
Acute Postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)
Secondary Outcomes (4)
Changes in Plasma Lipid and Lipoprotein panels
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)
Changes in insulin concentrations
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)
Changes in LDL oxidation
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)
Changes in F2-isoprostane concentrations
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)
Other Outcomes (2)
Changes in plasma glucose concentrations
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h).
Changes in polyphenol anthocyanin concentrations
Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h).
Study Arms (2)
Active Treatment Beverage
ACTIVE COMPARATORStrawberry powder and Blackcurrent extract
Placebo Treatment Beverage
PLACEBO COMPARATORPlacebo Beverage
Interventions
Strawberry and Blackcurrent extract
without active components
Eligibility Criteria
You may qualify if:
- Non-smoking healthy overweight or class I obesity adult men and women
- Age 40-65yr
- Weight stable
- Able to provide informed consent
- Able to comply and perform the procedures requested by the protocol.
You may not qualify if:
- Smokers or recent past smokers
- Men or women with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
- Diabetes
- Fasting blood glucose concentrations \>125 mg/dL
- Fasting Total Cholesterol \>250 mg/dL (6.47mmol/L)
- Fasting Triglycerides \>250 mg/dL (2.82 mmol/L)
- Fasting LDL cholesterol \>180 mg/dL (4.66 mmol/L)
- Uncontrolled blood pressure \>140 mmHg/90 mmHg
- Documented vascular disease
- Cancer other than skin (non-melanoma) in previous 5 years
- Lactating and/or pregnant
- Taking medications or dietary supplements eg., antioxidant supplements, lipid lowering medication, blood pressure lowering medications.
- Recent blood donors (within 3 months)
- Vegans
- Substance (alcohol or drug) abuser (within the last 2 years)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Nutrition Research Center
Chicago, Illinois, 60616, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Britt Burton-Freeman, Ph.D
Illinois Institute of Technology
- STUDY CHAIR
Indika Edirisinghe, Ph.D
Illinois Instutute of Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2012
First Posted
November 21, 2012
Study Start
December 1, 2012
Primary Completion
March 20, 2014
Study Completion
June 26, 2018
Last Updated
July 27, 2021
Record last verified: 2021-07